TCL Archive DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year February 27, 1987
TCL Archive Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015. November 23, 2005
TCL Archive New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet, January 19, 2007
TCL Archive FDA News: FDA Grants Accelerated Approval to Mekinist-Tafinlar Combination January 10, 2014